Great Novel Therapeutics Biotech & Medicals (7427.TWO)
TWD 36.15
(0.14%)
TWD 36.15
(0.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 4.85 Million | 540 Thousand | 630 Thousand | - | - |
| Cost of Revenue | 2.23 Million | 76 Thousand | 347 Thousand | - | - |
| Gross Profit | 2.61 Million | 464 Thousand | 283 Thousand | - | - |
| Operating Expenses | 2.61 Million | 57.9 Million | 36.8 Million | 29.88 Million | - |
| Selling, General and Administrative Expenses | 17.5 Million | 19.36 Million | 17.69 Million | 10.41 Million | - |
| Research and Development Expenses | 51.47 Million | 38.53 Million | 19.1 Million | 19.47 Million | - |
| Other Expenses | -729 Thousand | 723 Thousand | 149 Thousand | -1.39 Million | - |
| Cost and Expenses | 70.66 Million | 57.97 Million | 37.15 Million | 29.88 Million | - |
| Operating Income | -65.81 Million | -55.77 Million | -36.52 Million | -31.24 Million | - |
| Interest Expense | 91 Thousand | - | - | 21 Thousand | - |
| Income Tax Expense | - | - | - | - | - |
| Earnings before Tax | -61.54 Million | -55.77 Million | -35.85 Million | -31.26 Million | - |
| Net Income | -61.54 Million | -55.77 Million | -35.85 Million | -31.26 Million | - |
| Earnings Per Share Basic | -1.70 | -2.31 | -1.70 | -1.97 | -2.20 |
| Earnings Per Share Diluted | -1.70 | -2.31 | -1.70 | -1.97 | -2.20 |
| Weighted Average Shares Outstanding | 36.28 Million | 24.14 Million | 21.08 Million | 15.84 Million | 13.56 Million |
| Weighted Average Shares Outstanding (Diluted) | 36.28 Million | 24.15 Million | 21.08 Million | 15.84 Million | 13.56 Million |
| Gross Margin | 0.54 | 0.86 | 0.45 | - | - |
| EBIT Margin | -11.32 | -99.92 | -55.59 | - | - |
| Profit Margin | -12.69 | -103.29 | -56.92 | - | - |
| EBITDA | -54.91 Million | -53.95 Million | -35.07 Million | -30.2 Million | -28.89 Million |
| Earnings Before Tax Margin | -13.57 | -103.29 | -57.97 | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 263.5 Thousand | 263.5 Thousand | 44 Thousand | 4.85 Million | 44 Thousand | 2.38 Million |
| Cost of Revenue | 100 Thousand | 100 Thousand | 21.5 Thousand | 2.23 Million | 21.5 Thousand | - |
| Gross Profit | 163.5 Thousand | 163.5 Thousand | 22.5 Thousand | 2.61 Million | 22.5 Thousand | 2.38 Million |
| Operating Expenses | 32.69 Million | 32.72 Million | 15.07 Million | 68.97 Million | 15.07 Million | 20.45 Million |
| Selling, General and Administrative Expenses | 8.34 Million | 8.34 Million | 5.23 Million | - | 5.23 Million | 3.88 Million |
| Research and Development Expenses | 24.34 Million | 24.34 Million | 9.98 Million | - | 9.98 Million | 16.57 Million |
| Other Expenses | - | - | - | -420 Thousand | - | - |
| Cost and Expenses | 32.79 Million | 32.82 Million | 15.09 Million | 71.21 Million | 15.09 Million | 20.45 Million |
| Operating Income | -32.53 Million | -32.53 Million | -14.83 Million | -61.44 Million | -14.83 Million | -18.07 Million |
| Interest Expense | - | - | - | 91 Thousand | - | - |
| Income Tax Expense | - | - | - | - | - | - |
| Earnings before Tax | -30.97 Million | -30.97 Million | -13.47 Million | -61.54 Million | -13.47 Million | -17.02 Million |
| Net Income | -30.97 Million | -30.97 Million | -13.47 Million | -61.54 Million | -13.47 Million | -17.02 Million |
| Earnings Per Share Basic | -0.80 | -0.80 | -0.35 | - | -0.35 | -0.50 |
| Earnings Per Share Diluted | -0.80 | -0.80 | -0.35 | - | -0.35 | -0.50 |
| Weighted Average Shares Outstanding | 38.72 Million | 38.72 Million | 38.16 Million | 36.28 Million | 38.16 Million | 34.22 Million |
| Weighted Average Shares Outstanding (Diluted) | 38.82 Million | 38.72 Million | 38.34 Million | 36.28 Million | 38.34 Million | 34.22 Million |
| Gross Margin | 0.62 | 0.62 | 0.51 | 0.54 | 0.51 | 1.00 |
| EBIT Margin | -119.62 | -116.87 | -317.68 | - | -317.68 | -7.41 |
| Profit Margin | -117.57 | -117.57 | -306.24 | -12.69 | -306.24 | -7.15 |
| EBITDA | -31.52 Million | -30.79 Million | -13.97 Million | - | -13.97 Million | -17.63 Million |
| Earnings Before Tax Margin | -123.46 | -123.46 | -337.15 | -12.67 | -337.15 | -7.59 |
SOL
TIRUPATIFL
0896
BAESF
NSARO
APTL